# DiaDexus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/diadexus

- Industry: Healthcare
- Headquarters: San Francisco, US
- Website: www.diadexus.com
- Total disclosed funding: $152M
- Latest round: Series F (Jan 6, 2009)
- Investors on record: 8

## About

DiaDexus, is based in San Francisco, US and is a medical diagnostics company and focused on the development and commercialization of patent-protected in vitro diagnostic products addressing significant unmet needs in cardiovascular disease.

## Funding rounds

- Series F, Jan 6, 2009, $9.1M — Scale Venture Partners, GlaxoSmithKline, Baker Brothers Advisors
- Series E, Nov 29, 2006, $40M — Burrill & Company, RHO, Scale Venture Partners, Mosaix Ventures, GlaxoSmithKline, Baker Brothers Advisors
- Series C, Apr 11, 2000, $103M — Scale Venture Partners, Bank of America, American Express

## Investors

- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series C, Series E, Series F
- Bank of America — Series C
- American Express — Series C
- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series E
- RHO (https://capitalatlas.ai/funds/rho) — Series E
- Mosaix Ventures (https://capitalatlas.ai/funds/mosaix-ventures) — Series E
- GlaxoSmithKline — Series E, Series F
- Baker Brothers Advisors (https://capitalatlas.ai/funds/baker-brothers-advisors) — Series E, Series F